Trends in Use and Expenditures for Brand-name Statins After Introduction of Generic Statins in the US, 2002-2018.

ABSTRACT:

Importance

The high and increasing expenditures for prescription medications in the US is a national problem.

Objective

To explore the association of generic statin competition on relevant use and cost savings and to provide use and expenditure trends for all available statins for private and public payers and for out-of-pocket spending.

Design, setting, and participants

This survey study evaluated data from the January 1, 2002, to December 31, 2018, Medical Expenditure Panel Survey by using a difference-in-differences analysis. Participants included noninstitutionalized individual statin users. Data were analyzed from November 1, 2020, to March 30, 2021.

Exposures

The market entry of 5 generic statin medications (atorvastatin, rosuvastatin, simvastatin, lovast

SUBMITTER: Lin SY 

PROVIDER: S-EPMC8609409 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature